Clinical Trials Update: July 2, 2007
Alzheimer Disease Rheumatoid Arthritis Nocturia
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate an investigational drug for Alzheimer's disease. Participants will receive study supervision by a board-certified neurologist, study related tests and exams, and the investigational drug at no cost. Compensation is available for time and travel.
The research site is in Phoenix, Ariz.
This study will evaluate the effectiveness of an investigational medication, taken in addition to methotrexate, to control the signs and symptoms of rheumatoid arthritis. Participants must be at least 18, have active rheumatoid arthritis, be taking 10 mg. to 25 mg. of methotrexate per week, and have at least six tender joints and at least six swollen joints.
The research site is in New Port Richey, Fla.
This study will test the safety and effectiveness of a fast-dissolving formulation of an investigational medication for nocturia. Participants must be 18 or older, and average two or more nightly trips to the bathroom to urinate. Patients must not take diuretics or water pills, and cannot have diabetes or uncontrolled high blood pressure.
The research site is in Tarzana, Calif.
Copyright 2007 Thomson CenterWatch. All rights reserved.